Exelixis Inc. buy BMO Capital Markets
Start price
30.10.24
/
50%
€30.68
Target price
30.10.25
€33.16
Performance (%)
7.99%
End price
31.10.25
€33.13
Summary
This prediction ended on 31.10.25 with a price of €33.13. The BUY prediction by BMO_Capital_Markets finished with a performance of 7.99%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | 0.936% | 0.936% | 26.365% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its price target raised by analysts at BMO Capital Markets from $29.00 to $36.00. They now have an "outperform" rating on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten